Similar articles

• [Prophylactic value of platelet anti-aggregants in coronary disease].

  Verstraete M. Verstraete M. Clin Ter. 1979 Oct 31;91(2):117-27. Clin Ter. 1979. PMID: 396098 Review. Italian. No abstract available.
• [Role of antiaggregant platelet drugs in thromboembolism].

  Tullio D. Tullio D. G Ital Cardiol. 1981;11(8):1131-40. G Ital Cardiol. 1981. PMID: 6173281 Review. Italian. No abstract available.
• [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].

  Offerhaus L. Offerhaus L. Ned Tijdschr Geneeskd. 1983 Apr 16;127(16):673-9. Ned Tijdschr Geneeskd. 1983. PMID: 6134240 Clinical Trial. Dutch. No abstract available.
• [Evaluation of antithrombin III activity in ischemic cardiopathy: changes due to treatment with platelet anti-aggregants].

  Avellone G, Mandalà V, Novo S, Davì G, Pinto A, Riolo FP. Avellone G, et al. Boll Soc Ital Cardiol. 1979;24(11):1229-33. Boll Soc Ital Cardiol. 1979. PMID: 261907 Italian. No abstract available.
• [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].

  Verstraete M. Verstraete M. Recenti Prog Med. 1980 Apr;68(4):361-81. Recenti Prog Med. 1980. PMID: 6992244 Review. Italian. No abstract available.